These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2389422)

  • 1. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation.
    Suzuki S; Hayashi R; Kenmochi T; Shimatani K; Fukuoka T; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1615-7. PubMed ID: 2389422
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic use of deoxyspergualin in living related renal transplantation.
    Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157
    [No Abstract]   [Full Text] [Related]  

  • 5. Experience gained from the administration of 15-deoxyspergualin for recurrent graft rejection in kidney transplant recipients.
    Takahara S; Jiang H; Takano Y; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1992 Aug; 24(4):1377-80. PubMed ID: 1496592
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
    Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
    [No Abstract]   [Full Text] [Related]  

  • 7. Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
    Kyo M; Ichikawa Y; Fukunishi Y; Hanafusa T; Nagano S; Takahara S; Ishibashi M; Okuyama A; Ihara H; Fujimoto N
    Transplant Proc; 1995 Feb; 27(1):1012-3. PubMed ID: 7878780
    [No Abstract]   [Full Text] [Related]  

  • 8. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
    Takahara S; Moutabarrik A; Kokado Y; Kameoka H; Takano Y; Zaid D; Ishibashi M; Sonoda T; Okuyama A
    Transplant Proc; 1993 Jun; 25(3):2254-8. PubMed ID: 8516891
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
    Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
    Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract]   [Full Text] [Related]  

  • 12. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxyspergualin: clinical experience.
    Gores PF
    Transplant Proc; 1996 Apr; 28(2):871-2. PubMed ID: 8623441
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of 15-deoxyspergualin for rejection in renal transplantation.
    Kozaki K; Kozaki M; Nagao T
    Transplant Proc; 1999; 31(1-2):1138-9. PubMed ID: 10083509
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppressive mechanisms and action of deoxyspergualin in experimental and clinical studies. Japanese Collaborative Transplant Study Group of NKT-01.
    Amemiya H
    Transplant Proc; 1995 Feb; 27(1):31-2. PubMed ID: 7879015
    [No Abstract]   [Full Text] [Related]  

  • 16. Addition of deoxyspergualin to standard triple immunosuppressive regimen in kidney transplantation.
    Seki T; Tanda K; Chikaraishi T; Takeuchi I; Kanagawa K; Togashi M; Koyanagi T
    Transplant Proc; 1996 Jun; 28(3):1352-3. PubMed ID: 8658690
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 15-deoxyspergualin on mononuclear cells from kidney recipients.
    Johansson-Borg A; Ohlman S; Groth CG
    Transplant Proc; 1992 Feb; 24(1):267-8. PubMed ID: 1539276
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of renal function in transplanted kidneys with a new immunosuppressive drug, 15-deoxyspergualin: treatment of chronic rejection.
    Iino Y; Ohzono E; Kawabe M; Matsunobu S; Takeuchi M; Hayama N; Hara K; Terashi A; Suzuki S; Amemiya H
    Transplant Proc; 1992 Aug; 24(4):1381-2. PubMed ID: 1496593
    [No Abstract]   [Full Text] [Related]  

  • 19. Further study of deoxyspergualin prophylaxis in living related renal transplantation.
    Okazaki H; Sato T; Amada N
    Transplant Proc; 1993 Feb; 25(1 Pt 1):772-3. PubMed ID: 8438475
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.